EANS-Adhoc: LIFEWATCH TEAMS WITH UNITEDHEALTHCARE, THE LARGEST HEALTHCARE INSURER IN THE UNITED STATES, AS A PREFERRED NATIONAL PROVIDER OF CARDIAC MONITORING SERVICES TO REDUCE PATIENT COSTS (with do

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Company Information/LifeWatch AG

21.02.2011

Neuhausen am Rheinfall/Switzerland und Rosemont/Illinois - LifeWatch
AG (SIX Swiss Exchange: LIFE), the leading provider of wireless
telemedicine, today announces an initiative with UnitedHealthcare
Insurance Company, an affiliate of United-Health Group (NYSE: UNH)
that will provide members insured by UnitedHealthcare in-network
access to LifeWatch cardiac monitoring services and technologies.
LifeWatch is proud to continue our preferred national relationship
that began December 1, 2006. The purpose of this initiative is to
substantially reduce patient co-pays and deductibles associated with
the use of out-of-network cardiac monitoring services provided by
other monitoring services.

You will find a PDF version of this press release at the end of this
message.

LifeWatch is the leading independent provider of remote cardiac
arrhythmia monitoring devices, home sleep studies and services in the
USA, which assist physicians and patients in the early detection and
treatment of arrhythmia and Obstructive Sleep Apnea (OSA), and can
thus prevent heart diseases, stroke, or sudden cardiac death.
Millions of people experience arrhythmia and sleep apnea. Typical
arrhythmia symptoms include palpitations, rapid heartbeat, dizziness,
chest pain and shortness of breath. OSA patients are at risk for a
multitude of comorbidities including atrial fibrillation. LifeWatch´s
services enable a physician who is treating a patient with arrhythmia
to prescribe his patient with a range of cardiac monitoring devices
that records irregularities in the heart´s electrical activity up to
a 30-day period. The recorded data is transmitted to the LifeWatch
call center, which processes the information and sends a detailed
report to the referring physician for interpretation and treatment
decisions. Making the LifeWatch services in-network simplifies the
process by which a doctor can prescribe them to patients who are
insured by UnitedHealthcare.

"LifeWatch is privileged to continue our existing relationship with
UnitedHealthcare," said Yacov Geva, LifeWatch president and CEO. "Our
agreement strengthens the position of our Client Executives when they
approach physicians, health care professionals, and hospitals that
are members of the UnitedHealthcare network. Our agreement also
provides UnitedHealthcare and their members with an all-inclusive
in-network provider for remote cardiac monitoring services.
UnitedHealthcare contracted providers are assured access to state of
the art devices and reporting for their patients´ cardiac monitoring
care."

LifeWatch is accredited from the Joint Commission on Accreditation of
Healthcare Organizations (The Joint Commission) under the program
classification of "Ambulatory Health Care Programs." LifeWatch is one
of only a few independent diagnostic testing facilities worldwide
that have received this Gold Seal of ApprovalTM.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall, Switzerland
and listed on SIX Swiss Exchange (LIFE), is the leading healthcare
technology and solutions company, specializing in advanced
telemedicine systems and wireless remote patient monitoring services.
LifeWatch provides services to high-risk and chronically ill
patients, health conscious consumers and wellness programs. LifeWatch
has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services, Inc., a leading US-based wireless
remote telemedicine provider. LifeWatch services include Home Sleep
Testing for Obstructive Sleep Apnea patients under the brand name
NiteWatch. For additional information, please visit www.lifewatch.com
and www.nitewatchservices.com.

About UnitedHealthcare:

UnitedHealth Group is a diversified health and well-being company
dedicated to helping people live healthier lives and making health
care work better. With headquarters in Minnetonka, Minn.,
UnitedHealth Group offers a broad spectrum of products and services
through six operating businesses: UnitedHealthcare Employer &
Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare
Community & State, OptumHealth, Ingenix and Prescription Solutions.
Through its family of businesses, UnitedHealth Group serves more than
75 million people worldwide. Visit www.unitedhealthgroup.com for more
information.

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward- looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/l6A8sZUQ

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 2448 | E-mail: wkim@lifewatch.com

Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail: lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
Berlin / free trade
SIX Swiss Exchange / Main Standard